AGP Picks
View all

Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on July 7, 2026

Ethos Laboratories Announces Exclusive U.S. Launch of CNSDose™, Following Successful MolDX® Technical Assessment
EliseAI Announces Elise Beyond Conference for Multifamily Operators to Unlock AI’s Full Potential
Praxis Precision Medicines and Remagine Labs Announce Strategic Collaboration to Develop Transdermal Ulixacaltamide for Essential Tremor
Zapata Quantum to Present at the Global Technology Virtual Investor Conference July 9th
Byrna Technologies Selects Acceleration Partners to Expand Creator Network and Relaunch Affiliate Marketing Program
Rocket Doctor AI Inc. Appoints Financial Growth Strategist Andrew Lau as Chief Financial Officer to Help Accelerate U.S. Expansion
zSpace Powers Immersive Career Exploration at Poland's New Laboratorium 4.0
authID Announces Strategic Partnership with SynerComm to Expand Biometric Identity Security Across Highly Regulated Enterprises
Diginex Appoints Jan-Jaap Verhoeve as Chief Commercial Officer to Accelerate Global Revenue Growth and Strategic Expansion
Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit
Forterra Reveals It Rapidly Manufactured and Deployed Autonomous Systems to Ukraine at Scale in Russo-Ukrainian War
Kahuna Labs Introduces AI-Powered Escalation Prevention to Help Enterprises Stop Escalations Before They Happen
Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026
Lumanity Strengthens Climate Commitment with SBTi (Science Based Targets Initiative) Validation for Near-Term Emissions Reduction Targets
Rezolve Ai Introduces Auditable AI, Completing the Foundation for Trusted Enterprise AI Commerce
Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026
BIO-key Regains Compliance with Nasdaq Listing Rules; Nasdaq Trading Resumes on Wednesday, July 8th
Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Science

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.